Riskpilot← Back to searchSign inGet full accessLLMedic AB
ABActiveOrg 5590915327Scheelegatan 10 Lgh 1303Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2024
SEK 1M
-5% vs 2023
EBITDA margin
26.0%
-26% vs 2023
Equity ratio
52.3%
Financial strength
Net profit 2024
SEK 172K
-24% vs 2023
| Revenue | SEK 1M | -5% |
| EBITDA | SEK 261K | -26% |
| Net profit | SEK 172K | -24% |
| Total assets | SEK 2,1M | -12% |
| Equity | SEK 1,1M | -22% |
| Employees | 0 | — |
Legal name
LLMedic AB
Org number
5590915327
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom området ögonsjukdomar. Konsulten är läkare och kommer utföra ögonundersökningar, bedömning av diagnos samt vid behov förskrivning av läkemedel. Konsulten kan även i vissa fall åta sig uppdrag från läkemedelsföretag, till exempel bedömning av olika forskningsstudier, bedömning av framtagande av nya läkemedel, ge synpunkter på redan registrerade läkemedel.
Address
Scheelegatan 10 Lgh 1303
Email
lillinger.larsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 148 | 1 485 | 1 310 | 1 062 | 1 004 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 546 | 743 | 672 | 351 | 261 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 546 | 743 | 672 | 351 | 261 |
| Net financials | — | — | — | 1 | 2 |
| Profit before tax | 408 | 613 | 501 | 290 | 225 |
| Tax | −89 | −129 | −105 | −64 | −53 |
| Net profit | 319 | 484 | 396 | 226 | 172 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 718 | 2 339 | 2 653 | 2 372 | 2 097 |
| Equity | 978 | 1 462 | 1 658 | 1 404 | 1 096 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 331 | 338 | 286 | 196 | 191 |
| Total debt | 331 | 338 | 286 | 196 | 191 |
EBITDA margin
26.0%
This company
15.8%
Market median
+65% vs market
20202024
Equity ratio
52.3%
This company
38.2%
Market median
+37% vs market
20202024
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
20202024
Net profit margin
17.1%
This company
8.1%
Market median
+111% vs market
20202024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20202024
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LLMedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lill-Inger Larsson | Board of Directors | 0 companies |
| Bo Sune Allan Larsson | Deputy Board Member | 0 companies |